Complete tumor response after concomitant treatment with lenvatinib and radioembolization with Ytrio-90 of advanced stage hepatocarcinoma
Gespeichert in:
| Veröffentlicht in: | Gastroenterología y hepatología 2024-06, Vol.47 (6), p.620 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 6 |
| container_start_page | 620 |
| container_title | Gastroenterología y hepatología |
| container_volume | 47 |
| creator | Martínez Benito, Belén González Pintor, Víctor Del Campo Del Val, Lourdes García-Buey, Luisa |
| description | |
| doi_str_mv | 10.1016/j.gastrohep.2023.09.005 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_37742831</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>37742831</sourcerecordid><originalsourceid>FETCH-LOGICAL-p178t-d3d520055ca63e18bad40c575c7d6cdef7451b0dc3ca500cf7a85f44859efa263</originalsourceid><addsrcrecordid>eNo1UEtOwzAU9AJES-EK4Ask-BPH6RJV_KRKbGDBqnqxX1pXsR05bhHcgFsTqbCa0Wg0mhlCbjkrOeP13b7cwphT3OFQCiZkyZYlY-qMzJngrFCaqRm5HMc9Y0JJsbwgM6l1JRrJ5-RnFf3QY0aaDz4mmnAcYhiRQpcxURODid5lCJnmhJA9TuzT5R3tMRwhu-BaCsHSBNZF9G3s3fckx3ByfeTkYrFkNHYU7BGCQUvHDFukU1_I0UAyLkQPV-S8g37E6z9ckPfHh7fVc7F-fXpZ3a-LgesmF1ZaJaZ5ykAtkTct2IoZpZXRtjYWO10p3jJrpAHFmOk0NKqrqkYtsQNRywW5OeUOh9aj3QzJeUhfm_9P5C-j-Gl9</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Complete tumor response after concomitant treatment with lenvatinib and radioembolization with Ytrio-90 of advanced stage hepatocarcinoma</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Martínez Benito, Belén ; González Pintor, Víctor ; Del Campo Del Val, Lourdes ; García-Buey, Luisa</creator><creatorcontrib>Martínez Benito, Belén ; González Pintor, Víctor ; Del Campo Del Val, Lourdes ; García-Buey, Luisa</creatorcontrib><identifier>ISSN: 0210-5705</identifier><identifier>DOI: 10.1016/j.gastrohep.2023.09.005</identifier><identifier>PMID: 37742831</identifier><language>eng ; spa</language><publisher>Spain</publisher><subject>Aged ; Antineoplastic Agents - adverse effects ; Antineoplastic Agents - therapeutic use ; Carcinoma, Hepatocellular - therapy ; Combined Modality Therapy ; Embolization, Therapeutic ; Humans ; Liver Neoplasms - radiotherapy ; Liver Neoplasms - secondary ; Male ; Middle Aged ; Neoplasm Staging ; Phenylurea Compounds - adverse effects ; Phenylurea Compounds - therapeutic use ; Quinolines - therapeutic use ; Radiopharmaceuticals - therapeutic use ; Remission Induction ; Yttrium Radioisotopes - therapeutic use</subject><ispartof>Gastroenterología y hepatología, 2024-06, Vol.47 (6), p.620</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37742831$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martínez Benito, Belén</creatorcontrib><creatorcontrib>González Pintor, Víctor</creatorcontrib><creatorcontrib>Del Campo Del Val, Lourdes</creatorcontrib><creatorcontrib>García-Buey, Luisa</creatorcontrib><title>Complete tumor response after concomitant treatment with lenvatinib and radioembolization with Ytrio-90 of advanced stage hepatocarcinoma</title><title>Gastroenterología y hepatología</title><addtitle>Gastroenterol Hepatol</addtitle><subject>Aged</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Carcinoma, Hepatocellular - therapy</subject><subject>Combined Modality Therapy</subject><subject>Embolization, Therapeutic</subject><subject>Humans</subject><subject>Liver Neoplasms - radiotherapy</subject><subject>Liver Neoplasms - secondary</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Phenylurea Compounds - adverse effects</subject><subject>Phenylurea Compounds - therapeutic use</subject><subject>Quinolines - therapeutic use</subject><subject>Radiopharmaceuticals - therapeutic use</subject><subject>Remission Induction</subject><subject>Yttrium Radioisotopes - therapeutic use</subject><issn>0210-5705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1UEtOwzAU9AJES-EK4Ask-BPH6RJV_KRKbGDBqnqxX1pXsR05bhHcgFsTqbCa0Wg0mhlCbjkrOeP13b7cwphT3OFQCiZkyZYlY-qMzJngrFCaqRm5HMc9Y0JJsbwgM6l1JRrJ5-RnFf3QY0aaDz4mmnAcYhiRQpcxURODid5lCJnmhJA9TuzT5R3tMRwhu-BaCsHSBNZF9G3s3fckx3ByfeTkYrFkNHYU7BGCQUvHDFukU1_I0UAyLkQPV-S8g37E6z9ckPfHh7fVc7F-fXpZ3a-LgesmF1ZaJaZ5ykAtkTct2IoZpZXRtjYWO10p3jJrpAHFmOk0NKqrqkYtsQNRywW5OeUOh9aj3QzJeUhfm_9P5C-j-Gl9</recordid><startdate>202406</startdate><enddate>202406</enddate><creator>Martínez Benito, Belén</creator><creator>González Pintor, Víctor</creator><creator>Del Campo Del Val, Lourdes</creator><creator>García-Buey, Luisa</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>202406</creationdate><title>Complete tumor response after concomitant treatment with lenvatinib and radioembolization with Ytrio-90 of advanced stage hepatocarcinoma</title><author>Martínez Benito, Belén ; González Pintor, Víctor ; Del Campo Del Val, Lourdes ; García-Buey, Luisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p178t-d3d520055ca63e18bad40c575c7d6cdef7451b0dc3ca500cf7a85f44859efa263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; spa</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Carcinoma, Hepatocellular - therapy</topic><topic>Combined Modality Therapy</topic><topic>Embolization, Therapeutic</topic><topic>Humans</topic><topic>Liver Neoplasms - radiotherapy</topic><topic>Liver Neoplasms - secondary</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Phenylurea Compounds - adverse effects</topic><topic>Phenylurea Compounds - therapeutic use</topic><topic>Quinolines - therapeutic use</topic><topic>Radiopharmaceuticals - therapeutic use</topic><topic>Remission Induction</topic><topic>Yttrium Radioisotopes - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martínez Benito, Belén</creatorcontrib><creatorcontrib>González Pintor, Víctor</creatorcontrib><creatorcontrib>Del Campo Del Val, Lourdes</creatorcontrib><creatorcontrib>García-Buey, Luisa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Gastroenterología y hepatología</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martínez Benito, Belén</au><au>González Pintor, Víctor</au><au>Del Campo Del Val, Lourdes</au><au>García-Buey, Luisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complete tumor response after concomitant treatment with lenvatinib and radioembolization with Ytrio-90 of advanced stage hepatocarcinoma</atitle><jtitle>Gastroenterología y hepatología</jtitle><addtitle>Gastroenterol Hepatol</addtitle><date>2024-06</date><risdate>2024</risdate><volume>47</volume><issue>6</issue><spage>620</spage><pages>620-</pages><issn>0210-5705</issn><cop>Spain</cop><pmid>37742831</pmid><doi>10.1016/j.gastrohep.2023.09.005</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0210-5705 |
| ispartof | Gastroenterología y hepatología, 2024-06, Vol.47 (6), p.620 |
| issn | 0210-5705 |
| language | eng ; spa |
| recordid | cdi_pubmed_primary_37742831 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Aged Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Carcinoma, Hepatocellular - therapy Combined Modality Therapy Embolization, Therapeutic Humans Liver Neoplasms - radiotherapy Liver Neoplasms - secondary Male Middle Aged Neoplasm Staging Phenylurea Compounds - adverse effects Phenylurea Compounds - therapeutic use Quinolines - therapeutic use Radiopharmaceuticals - therapeutic use Remission Induction Yttrium Radioisotopes - therapeutic use |
| title | Complete tumor response after concomitant treatment with lenvatinib and radioembolization with Ytrio-90 of advanced stage hepatocarcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T06%3A03%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complete%20tumor%20response%20after%20concomitant%20treatment%20with%20lenvatinib%20and%20radioembolization%20with%20Ytrio-90%20of%20advanced%20stage%20hepatocarcinoma&rft.jtitle=Gastroenterolog%C3%ADa%20y%20hepatolog%C3%ADa&rft.au=Mart%C3%ADnez%20Benito,%20Bel%C3%A9n&rft.date=2024-06&rft.volume=47&rft.issue=6&rft.spage=620&rft.pages=620-&rft.issn=0210-5705&rft_id=info:doi/10.1016/j.gastrohep.2023.09.005&rft_dat=%3Cpubmed%3E37742831%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/37742831&rfr_iscdi=true |